Sunflower Pharmaceutical Group Co Ltd
SZSE:002737
Sunflower Pharmaceutical Group Co Ltd
SZSE:002737
Price:
29.89 CNY
-0.7%
Market Closed
Updated:
Jun 7, 2024
Income Statement
Earnings Waterfall
Sunflower Pharmaceutical Group Co Ltd
Sunflower Pharmaceutical Group Co Ltd
|
Revenue
|
5.5B
CNY
|
|
Cost of Revenue
|
-2.5B
CNY
|
|
Gross Profit
|
3B
CNY
|
|
Operating Expenses
|
-1.8B
CNY
|
|
Operating Income
|
1.1B
CNY
|
|
Other Expenses
|
-151.6m
CNY
|
|
Net Income
|
968.2m
CNY
|
Income Statement
Sunflower Pharmaceutical Group Co Ltd
Sunflower Pharmaceutical Group Co Ltd
Currency: CNY
| Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||
| Revenue |
2 719
N/A
|
2 821
+4%
|
2 980
+6%
|
2 981
+0%
|
3 035
+2%
|
3 094
+2%
|
3 057
-1%
|
3 045
0%
|
3 364
+10%
|
3 435
+2%
|
3 785
+10%
|
3 855
+2%
|
3 855
N/A
|
4 111
+7%
|
4 235
+3%
|
4 369
+3%
|
4 472
+2%
|
4 594
+3%
|
4 523
-2%
|
4 488
-1%
|
4 371
-3%
|
4 069
-7%
|
3 585
-12%
|
3 427
-4%
|
3 462
+1%
|
3 769
+9%
|
3 963
+5%
|
4 271
+8%
|
4 461
+4%
|
4 443
0%
|
4 608
+4%
|
4 675
+1%
|
5 095
+9%
|
5 662
+11%
|
5 879
+4%
|
6 100
+4%
|
5 700
-7%
|
5 453
-4%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(1 038)
|
(1 151)
|
(1 259)
|
(1 307)
|
(1 347)
|
(1 403)
|
(1 407)
|
(1 385)
|
(1 413)
|
(1 488)
|
(1 615)
|
(1 605)
|
(1 560)
|
(1 734)
|
(1 789)
|
(1 895)
|
(1 838)
|
(1 970)
|
(1 946)
|
(1 909)
|
(1 831)
|
(1 758)
|
(1 540)
|
(1 482)
|
(1 451)
|
(1 618)
|
(1 696)
|
(1 826)
|
(1 823)
|
(1 862)
|
(1 916)
|
(1 923)
|
(2 157)
|
(2 449)
|
(2 548)
|
(2 674)
|
(2 493)
|
(2 500)
|
|
| Gross Profit |
1 681
N/A
|
1 669
-1%
|
1 721
+3%
|
1 675
-3%
|
1 688
+1%
|
1 691
+0%
|
1 650
-2%
|
1 660
+1%
|
1 951
+17%
|
1 947
0%
|
2 170
+11%
|
2 250
+4%
|
2 296
+2%
|
2 377
+4%
|
2 445
+3%
|
2 475
+1%
|
2 634
+6%
|
2 623
0%
|
2 577
-2%
|
2 580
+0%
|
2 541
-2%
|
2 311
-9%
|
2 045
-12%
|
1 945
-5%
|
2 011
+3%
|
2 150
+7%
|
2 268
+5%
|
2 445
+8%
|
2 638
+8%
|
2 580
-2%
|
2 692
+4%
|
2 752
+2%
|
2 938
+7%
|
3 213
+9%
|
3 331
+4%
|
3 426
+3%
|
3 208
-6%
|
2 953
-8%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(1 266)
|
(1 237)
|
(1 317)
|
(1 304)
|
(1 354)
|
(1 351)
|
(1 357)
|
(1 398)
|
(1 604)
|
(1 601)
|
(1 751)
|
(1 734)
|
(1 743)
|
(1 799)
|
(1 813)
|
(1 844)
|
(1 934)
|
(1 883)
|
(1 831)
|
(1 796)
|
(1 796)
|
(1 576)
|
(1 386)
|
(1 291)
|
(1 224)
|
(1 295)
|
(1 458)
|
(1 627)
|
(1 810)
|
(1 796)
|
(1 739)
|
(1 761)
|
(1 837)
|
(1 918)
|
(1 993)
|
(2 019)
|
(1 907)
|
(1 833)
|
|
| Selling, General & Administrative |
(1 236)
|
(1 230)
|
(1 310)
|
(1 298)
|
(1 323)
|
(1 348)
|
(1 355)
|
(1 395)
|
(1 494)
|
(1 590)
|
(1 744)
|
(1 659)
|
(1 641)
|
(1 752)
|
(1 765)
|
(1 841)
|
(1 835)
|
(1 848)
|
(1 782)
|
(1 763)
|
(1 684)
|
(1 509)
|
(1 313)
|
(1 219)
|
(1 199)
|
(1 271)
|
(1 426)
|
(1 565)
|
(1 684)
|
(1 696)
|
(1 659)
|
(1 681)
|
(1 774)
|
(1 867)
|
(1 952)
|
(1 979)
|
(1 852)
|
(1 836)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(67)
|
0
|
0
|
0
|
(107)
|
0
|
0
|
(31)
|
(114)
|
(89)
|
(126)
|
(125)
|
(110)
|
(105)
|
(99)
|
(92)
|
(99)
|
(113)
|
(115)
|
(142)
|
(122)
|
(133)
|
(132)
|
(132)
|
(88)
|
(102)
|
(95)
|
(95)
|
(118)
|
(130)
|
|
| Depreciation & Amortization |
(30)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
(43)
|
0
|
0
|
0
|
(44)
|
0
|
0
|
0
|
(50)
|
0
|
0
|
0
|
(52)
|
0
|
0
|
0
|
(53)
|
0
|
0
|
0
|
(60)
|
0
|
0
|
0
|
(57)
|
0
|
0
|
0
|
(63)
|
0
|
|
| Other Operating Expenses |
(0)
|
(7)
|
(7)
|
(6)
|
(0)
|
(3)
|
(2)
|
(3)
|
(0)
|
(11)
|
(7)
|
(75)
|
48
|
(48)
|
(48)
|
28
|
64
|
55
|
77
|
91
|
49
|
39
|
26
|
19
|
126
|
88
|
83
|
79
|
57
|
33
|
53
|
52
|
83
|
50
|
55
|
55
|
127
|
134
|
|
| Operating Income |
415
N/A
|
432
+4%
|
404
-6%
|
371
-8%
|
333
-10%
|
340
+2%
|
293
-14%
|
262
-11%
|
346
+32%
|
346
+0%
|
419
+21%
|
516
+23%
|
553
+7%
|
578
+5%
|
632
+9%
|
631
0%
|
700
+11%
|
741
+6%
|
746
+1%
|
784
+5%
|
744
-5%
|
736
-1%
|
659
-10%
|
654
-1%
|
787
+20%
|
855
+9%
|
810
-5%
|
818
+1%
|
828
+1%
|
784
-5%
|
953
+22%
|
991
+4%
|
1 101
+11%
|
1 294
+18%
|
1 338
+3%
|
1 407
+5%
|
1 301
-8%
|
1 120
-14%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(31)
|
(32)
|
(17)
|
(10)
|
7
|
13
|
7
|
6
|
(3)
|
(2)
|
(3)
|
(2)
|
0
|
1
|
8
|
10
|
1
|
16
|
14
|
11
|
13
|
7
|
10
|
13
|
22
|
27
|
27
|
27
|
37
|
26
|
30
|
22
|
2
|
11
|
21
|
37
|
63
|
68
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
2
|
40
|
40
|
32
|
15
|
(11)
|
(11)
|
(3)
|
2
|
4
|
4
|
(1)
|
(44)
|
(44)
|
(44)
|
(40)
|
18
|
86
|
87
|
87
|
(19)
|
8
|
8
|
8
|
3
|
3
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
23
|
21
|
30
|
43
|
62
|
78
|
89
|
78
|
80
|
61
|
47
|
52
|
10
|
10
|
(1)
|
(1)
|
5
|
5
|
16
|
9
|
19
|
17
|
3
|
4
|
2
|
43
|
98
|
96
|
12
|
(33)
|
(88)
|
(88)
|
(3)
|
(4)
|
(1)
|
(8)
|
(11)
|
(13)
|
|
| Pre-Tax Income |
407
N/A
|
422
+4%
|
418
-1%
|
404
-3%
|
401
-1%
|
431
+7%
|
388
-10%
|
346
-11%
|
422
+22%
|
405
-4%
|
462
+14%
|
565
+22%
|
565
0%
|
629
+11%
|
679
+8%
|
672
-1%
|
720
+7%
|
751
+4%
|
766
+2%
|
800
+5%
|
778
-3%
|
763
-2%
|
676
-11%
|
671
-1%
|
767
+14%
|
881
+15%
|
891
+1%
|
901
+1%
|
895
-1%
|
863
-3%
|
981
+14%
|
1 011
+3%
|
1 081
+7%
|
1 309
+21%
|
1 366
+4%
|
1 445
+6%
|
1 355
-6%
|
1 178
-13%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(76)
|
(77)
|
(77)
|
(76)
|
(74)
|
(89)
|
(72)
|
(85)
|
(83)
|
(65)
|
(99)
|
(97)
|
(95)
|
(115)
|
(115)
|
(112)
|
(113)
|
(117)
|
(129)
|
(139)
|
(143)
|
(145)
|
(115)
|
(112)
|
(147)
|
(179)
|
(173)
|
(171)
|
(132)
|
(110)
|
(148)
|
(165)
|
(171)
|
(198)
|
(203)
|
(185)
|
(190)
|
(178)
|
|
| Income from Continuing Operations |
331
|
345
|
341
|
328
|
328
|
342
|
317
|
261
|
339
|
340
|
362
|
469
|
470
|
514
|
565
|
560
|
608
|
634
|
637
|
661
|
635
|
618
|
560
|
559
|
620
|
702
|
718
|
729
|
762
|
754
|
834
|
846
|
910
|
1 111
|
1 163
|
1 260
|
1 165
|
1 000
|
|
| Income to Minority Interest |
(30)
|
(33)
|
(22)
|
(21)
|
(21)
|
(23)
|
(26)
|
(31)
|
(36)
|
(35)
|
(34)
|
(42)
|
(46)
|
(42)
|
(49)
|
(37)
|
(45)
|
(54)
|
(51)
|
(70)
|
(70)
|
(62)
|
(63)
|
(50)
|
(36)
|
(46)
|
(64)
|
(61)
|
(58)
|
(56)
|
(35)
|
(33)
|
(43)
|
(57)
|
(59)
|
(51)
|
(46)
|
(32)
|
|
| Net Income (Common) |
301
N/A
|
312
+4%
|
319
+2%
|
307
-4%
|
307
0%
|
319
+4%
|
291
-9%
|
230
-21%
|
303
+32%
|
305
+1%
|
328
+8%
|
426
+30%
|
424
-1%
|
472
+11%
|
515
+9%
|
524
+2%
|
563
+8%
|
580
+3%
|
586
+1%
|
591
+1%
|
565
-4%
|
556
-2%
|
497
-11%
|
509
+2%
|
585
+15%
|
656
+12%
|
655
0%
|
668
+2%
|
705
+5%
|
698
-1%
|
799
+14%
|
813
+2%
|
867
+7%
|
1 054
+22%
|
1 104
+5%
|
1 209
+10%
|
1 119
-7%
|
968
-13%
|
|
| EPS (Diluted) |
1.38
N/A
|
0.53
-62%
|
0.54
+2%
|
0.54
N/A
|
0.53
-2%
|
0.55
+4%
|
0.5
-9%
|
0.4
-20%
|
0.52
+30%
|
0.53
+2%
|
0.57
+8%
|
0.73
+28%
|
0.73
N/A
|
0.81
+11%
|
0.88
+9%
|
0.9
+2%
|
0.96
+7%
|
0.99
+3%
|
1
+1%
|
1.01
+1%
|
0.97
-4%
|
0.95
-2%
|
0.85
-11%
|
0.87
+2%
|
1
+15%
|
1.12
+12%
|
1.12
N/A
|
1.14
+2%
|
1.21
+6%
|
1.19
-2%
|
1.36
+14%
|
1.39
+2%
|
1.48
+6%
|
1.8
+22%
|
1.88
+4%
|
2.06
+10%
|
1.92
-7%
|
1.66
-14%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
